Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0002820 | negative regulation of adaptive immune response | 19/2508 | 45/18670 | 0.00000188 | 0.0000445 | 0.0000299 | 19 | RABC85 | |
BP | GO:0072676 | lymphocyte migration | 34/2508 | 111/18670 | 0.00000195 | 0.0000461 | 0.000031 | 34 | RABC85 | |
BP | GO:0030323 | respiratory tube development | 47/2508 | 176/18670 | 0.00000201 | 0.0000474 | 0.0000319 | 47 | RABC85 | |
BP | GO:0043368 | positive T cell selection | 16/2508 | 34/18670 | 0.00000214 | 0.0000502 | 0.0000338 | 16 | RABC85 | |
BP | GO:0032479 | regulation of type I interferon production | 37/2508 | 126/18670 | 0.00000217 | 0.0000508 | 0.0000342 | 37 | RABC85 | |
BP | GO:0044282 | small molecule catabolic process | 95/2508 | 445/18670 | 0.00000225 | 0.0000523 | 0.0000352 | 95 | RABC85 | |
BP | GO:0006066 | alcohol metabolic process | 81/2508 | 364/18670 | 0.00000235 | 0.0000545 | 0.0000367 | 81 | RABC85 | |
BP | GO:0001655 | urogenital system development | 75/2508 | 330/18670 | 0.00000242 | 0.000056 | 0.0000377 | 75 | RABC85 | |
BP | GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 34/2508 | 112/18670 | 0.00000244 | 0.0000562 | 0.0000378 | 34 | RABC85 | |
BP | GO:0043491 | protein kinase B signaling | 64/2508 | 269/18670 | 0.00000264 | 0.0000605 | 0.0000407 | 64 | RABC85 | |
BP | GO:0000187 | activation of MAPK activity | 42/2508 | 152/18670 | 0.00000269 | 0.0000614 | 0.0000413 | 42 | RABC85 | |
BP | GO:0032655 | regulation of interleukin-12 production | 21/2508 | 54/18670 | 0.00000272 | 0.000062 | 0.0000417 | 21 | RABC85 | |
BP | GO:0007229 | integrin-mediated signaling pathway | 32/2508 | 103/18670 | 0.00000275 | 0.0000622 | 0.0000418 | 32 | RABC85 | |
BP | GO:1902106 | negative regulation of leukocyte differentiation | 32/2508 | 103/18670 | 0.00000275 | 0.0000622 | 0.0000418 | 32 | RABC85 | |
BP | GO:0043300 | regulation of leukocyte degranulation | 19/2508 | 46/18670 | 0.0000028 | 0.0000627 | 0.0000421 | 19 | RABC85 | |
BP | GO:0016054 | organic acid catabolic process | 65/2508 | 275/18670 | 0.0000028 | 0.0000627 | 0.0000421 | 65 | RABC85 | |
BP | GO:0046395 | carboxylic acid catabolic process | 65/2508 | 275/18670 | 0.0000028 | 0.0000627 | 0.0000421 | 65 | RABC85 | |
BP | GO:0006644 | phospholipid metabolic process | 92/2508 | 430/18670 | 0.00000293 | 0.0000654 | 0.000044 | 92 | RABC85 | |
BP | GO:0043434 | response to peptide hormone | 93/2508 | 436/18670 | 0.00000297 | 0.000066 | 0.0000444 | 93 | RABC85 | |
BP | GO:0031098 | stress-activated protein kinase signaling cascade | 72/2508 | 315/18670 | 0.00000308 | 0.0000682 | 0.0000459 | 72 | RABC85 | |
BP | GO:0016049 | cell growth | 101/2508 | 484/18670 | 0.00000316 | 0.0000698 | 0.0000469 | 101 | RABC85 | |
BP | GO:0052548 | regulation of endopeptidase activity | 91/2508 | 425/18670 | 0.00000321 | 0.0000703 | 0.0000473 | 91 | RABC85 | |
BP | GO:0030500 | regulation of bone mineralization | 26/2508 | 76/18670 | 0.00000321 | 0.0000703 | 0.0000473 | 26 | RABC85 | |
BP | GO:0050729 | positive regulation of inflammatory response | 42/2508 | 153/18670 | 0.00000323 | 0.0000705 | 0.0000474 | 42 | RABC85 | |
BP | GO:0032606 | type I interferon production | 37/2508 | 128/18670 | 0.00000328 | 0.0000714 | 0.000048 | 37 | RABC85 | |
BP | GO:0061008 | hepaticobiliary system development | 39/2508 | 138/18670 | 0.00000332 | 0.0000719 | 0.0000484 | 39 | RABC85 | |
BP | GO:0032735 | positive regulation of interleukin-12 production | 16/2508 | 35/18670 | 0.00000345 | 0.0000746 | 0.0000501 | 16 | RABC85 | |
BP | GO:0070527 | platelet aggregation | 22/2508 | 59/18670 | 0.00000361 | 0.0000777 | 0.0000522 | 22 | RABC85 | |
BP | GO:0097305 | response to alcohol | 57/2508 | 233/18670 | 0.00000367 | 0.0000788 | 0.000053 | 57 | RABC85 | |
BP | GO:0060348 | bone development | 54/2508 | 217/18670 | 0.00000381 | 0.0000814 | 0.0000547 | 54 | RABC85 |